Key facts
- It has raised $930K; the latest was Early Stage VC ($390K) in Dec 2024.
- Notable investors include Incubate Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Time Prediction
- ·The full record, as it builds
Funding rounds
No funding rounds for Time Prediction are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Time Prediction
Developer of predictive health technology designed for early disease detection. The company's platform combines induced pluripotent stem cell modeling with computational analysis to identify early pathological changes, support diagnostic drug and device development, and generate research data for neurological conditions, enabling medical researchers and healthcare organizations to advance early intervention and disease prediction strategies.
- Sector
- Healthcare
- HQ
- Kyoto, Japan
- Founded
- 2021
- Website
- timepre.com/
- Ownership
- Privately Held (backing)
Time Prediction doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Time Prediction shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Time Prediction in its N-PORT filings yet. We sweep new filings monthly.